Neurocrine Biosciences Stock News

Australian Petroleum Production and Exploration Association (APPEA) has highlighted the critical role oil and gas plays in providing energy to the Australian industry and households. The association�

Focus more on businesses and less on anchoring to past prices. Uncertainty is increasing with the S&P 500 in no man's land. The best sectors across large cap, m

The FDA approves AbbVie's (ABBV) Oriahnn oral capsule for checking heavy menstrual bleeding related to uterine fibroids in pre-menopausal women. It will be sold in US markets by June-end.

Stocks Analysis by Investing.com (Charley Blaine/Investing.com) covering: Nasdaq 100, S&P 500, Dow Jones Industrial Average, US SmallCap 2000. Read Investing.com (Charley Blaine/Investing.com)'s lates

Biotech stocks could not sustain the uptrend in the holiday-shortened week, even as traders digested COVID-19-related news flow, clinical readouts, ASCO presentations and a few...

An AbbVie drug that treats pain in the uterus has notched an additional FDA approval for addressing heavy menstrual bleeding associated with uterine

AbbVie (NYSE: ABBV), in cooperation with Neurocrine Biosciences, Inc. (Nasdaq: NBIX), announced that the U.S. Food and Drug Administration (FDA) approved ORIAHNN™ (elagolix, estradiol, and norethind

Strike Energy will partner with AGIG for the development of a 50 terajoules a day (TJ/day) plant for the processing of gas from the West Erregulla phase one development in Western Australia. As part o

Stocks Analysis by Zacks Investment Research covering: SPDR S&P 500, Adobe Systems Incorporated, Northern Trust Corporation, Akamai Technologies Inc. Read Zacks Investment Research's latest article on

Minister Richard Bruton has tasked officials with seeing whether the €3bn National Broadband Plan could be rolled out faster than originally planned.

Oil and gas company Beach Energy has applied for a consent to discharge trace amounts of harmful substances from the deck drains of a mobile offshore drilling unit (MODU) as it is preparing for explor

IFG Advisory LLC trimmed its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) by 49.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securitie

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Jefferies Virtual Healthcare Conference at 11:00 a.m. ET on Tuesday, June 2, 2020. Kevin Gorman, Chief Executive Officer, will present a